Editors' ChoiceCancer An aspirin a day keeps metastasis at bay Bethany KerrDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. Email: bkerr{at}wakehealth.edu See allHide authors and affiliations Science Translational Medicine 17 Apr 2019:Vol. 11, Issue 488, eaax1728DOI: 10.1126/scitranslmed.aax1728 Bethany Kerr Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. Email: Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: bkerr@wakehealth.edu Article Info & Metrics eLetters Article Information vol. 11 no. 488 DOI: https://doi.org/10.1126/scitranslmed.aax1728 Published By: American Association for the Advancement of Science Print ISSN: 1946-6234 Online ISSN: 1946-6242 History: . Copyright & Usage: Copyright © 2019, American Association for the Advancement of Science Author Information Bethany KerrDepartment of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. Email: bkerr{at}wakehealth.edu Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: April 2019 to January 2021 AbstractFullPdf Apr 2019223519716 May 20191911551 Jun 201975142 Jul 201953763 Aug 201942670 Sep 201962600 Oct 201962630 Nov 2019111780 Dec 201981480 Jan 202042020 Feb 202062330 Mar 202031280 Apr 202044240 May 202011120 Jun 202001290 Jul 202031500 Aug 202021510 Sep 20201930 Oct 20207880 Nov 202031040 Dec 202071270 Jan 20212790 View Full Text
An aspirin a day keeps metastasis at bay By Bethany Kerr Science Translational Medicine17 Apr 2019 Aspirin’s inhibition of COX-1/thromboxane A2 prevents metastasis by blocking adhesion between platelets, circulating tumor cells, and the endothelium.
An aspirin a day keeps metastasis at bay By Bethany Kerr Science Translational Medicine17 Apr 2019 Aspirin’s inhibition of COX-1/thromboxane A2 prevents metastasis by blocking adhesion between platelets, circulating tumor cells, and the endothelium.